.RUT Russell 2000 Index
- 2066.980
- -2.687-0.13%
Get over by trading coins? This medtech company's stock soared 40% in one day after buying Bitcoin
① Semler Scientific announced the adoption of Bitcoin as its main reserve asset, which boosted its stock price by more than 40% at one point; ② The company has purchased 581 bitcoins with a total value of 40 million US dollars, including fees and expenses.
Application Software Is a Major Concern to Within Tech - Roth MKM
Beyond The Numbers: 5 Analysts Discuss ONE Gas Stock
During the last three months, 5 analysts shared their evaluations of ONE Gas (NYSE:OGS), revealing diverse outlooks from bullish to bearish.The following table summarizes their recent ratings, sheddin
Peeling Back The Layers: Exploring Koppers Hldgs Through Analyst Insights
Koppers Hldgs (NYSE:KOP) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The table below provides a snapshot of their recent
How Is The Market Feeling About B&G Foods?
B&G Foods's (NYSE:BGS) short percent of float has risen 20.4% since its last report. The company recently reported that it has 7.73 million shares sold short, which is 14.34% of all regular shares tha
Arcturus Therapeutics' Early Cystic Fibrosis Trial Results Encouraging - Analyst Cautiously Optimistic
On Tuesday, Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) announced that it will present Phase 1 results in healthy volunteers and new Phase 1b interim data in cystic fibrosis (CF) for ARCT-032 at
Kratos Rated Market Outperform at JMP Securities
Analyst Upgrades Duolingo, Sees Very Different User Experience Than ChatGPT
JMP Securities analyst Andrew Boone upgraded Duolingo, Inc. (NASDAQ:DUOL) from Market Perform to Market Outperform, with a price forecast of $260.Specifically, the analyst highlighted that a broader r
Sunstone Hotel Upgraded to Outperform at Baird Ahead of 2025 Inflection
MicroStrategy's Big Move: From Bitcoin Bet To Russell 1000 Inclusion
Michael Saylor's MicroStrategy Inc (NASDAQ:MSTR), a company widely recognized for its substantial Bitcoin holdings and innovative approach in the technology sector, has recently garnered significant a
Market Whales and Their Recent Bets on VKTX Options
Deep-pocketed investors have adopted a bearish approach towards Viking Therapeutics (NASDAQ:VKTX), and it's something market players shouldn't ignore. Our tracking of public options records at Benzing
OKLO, AMPS, ARTNA, and AY Are Among Utility Movers
What's Going On With FuelCell Energy Stock?
FuelCell Energy, Inc. (NASDAQ:FCEL) shares are trading higher Tuesday and the stock is up more than 25% over the past five days. What To Know:Earlier in May, President Joe Biden announced increased ta
Decoding 7 Analyst Evaluations For Beacon Roofing Supply
Ratings for Beacon Roofing Supply (NASDAQ:BECN) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The table below summarizes their recent ratin
What's Going On With Virgin Galactic Stock?
Virgin Galactic Holdings, Inc. (NYSE:SPCE) shares are soaring Tuesday on heavy trading volume. Here's a look at what's going on. The Details:Shares of Virgin Galactic Holdings are climbing higher Tues
Morgan Stanley Maintains Equal-Weight on ONE Gas, Raises Price Target to $61
Morgan Stanley analyst Stephen Byrd maintains ONE Gas (NYSE:OGS) with a Equal-Weight and raises the price target from $58 to $61.
ONE Gas Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/28/2024 2.01% Morgan Stanley $58 → $61 Maintains Equal-Weight 04/19/2024 7.02% Mizuho $63 → $64 Maintai
Morgan Stanley Maintains Equal-Weight on Spire, Raises Price Target to $67
Morgan Stanley analyst Stephen Byrd maintains Spire (NYSE:SR) with a Equal-Weight and raises the price target from $64 to $67.
Spire Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/28/2024 12.36% Morgan Stanley $64 → $67 Maintains Equal-Weight 05/02/2024 10.68% Wells Fargo $64 → $66
Travere Gains on Novartis Data for Filspari Rival, Calliditas Buyout